SCHEMBL7994728

SCHEMBL7994728

CCc1ccc(C(N)CC(=O)NC(=O)c2ccccc2)cc1CC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
GAA P10253 1/20 0.40
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
RAB9A P51151 1/20 0.38
CNR2 P34972 1/20 0.38
KCNK3 O14649 1/20 0.37
KCNK9 Q9NPC2 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
AHR P35869 1/20 0.37
ANPEP P15144 1/20 0.37
ENPEP Q07075 1/20 0.37
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27827515 0.82 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2GAAMEN1KMT2A
SCHEMBL825343 0.81 SMN1; SMN2 (0.49) ALDH1A1SMN1; SMN2POLBNPC1LMNA
SCHEMBL8863111 0.81 NPSR1 (0.55) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL7876150 0.77 MAPT (0.56) MEN1KMT2AMAPTMAPK1
SCHEMBL5280595 0.71 SLC1A2 (0.54) ALDH1A1SMN1; SMN2GAA
SCHEMBL7994479 0.69 MAPT (0.46) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL7876180 0.69 MEN1 (0.47) ALDH1A1SMN1; SMN2MEN1KMT2AHTT
SCHEMBL3363210 0.69 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2GAAMEN1KMT2A
SCHEMBL3364793 0.66 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GAAMEN1KMT2A
SCHEMBL25663640 0.65 HPGD (0.50) ALDH1A1SMN1; SMN2POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6284780-B1 PREVENT TUMOR NECROSIS FACTOR RETROVIRUS REPRODUCTION CELGENE CORPORATION 2001-09-04 US disclosed
EP-0800505-A1 NOVEL IMMUNOTHERAPEUTIC ARYL AMIDES CELGENE CORPORATION (US) 1997-10-15 EP disclosed
WO-1996020915-A1 NOVEL IMMUNOTHERAPEUTIC ARYL AMIDES CELGENE CORPORATION (US) 1996-07-11 WO disclosed